# Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

> **NCT02832297** · NA · UNKNOWN · sponsor: **Crescendo Bioscience** · enrollment: 318 (estimated)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **OTHER:** Vectra DA
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT02832297
- **Lead sponsor:** Crescendo Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2022-08
- **Final completion:** 2022-08
- **Target enrollment:** 318 (ESTIMATED)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02832297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02832297, "Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02832297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*